Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-19

Clinical Trial Update: Two Dose Regimens of Nifedipine for the Management of Preterm Labor [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating two nifedipine dosing regimens for the management of preterm labor has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nifedipine (nifedipine)

Snippet

Sponsor: American University of Beirut Medical Center | Conditions: Labor, Premature | Phase 3 | Status: TERMINATED